Search results
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit
Simply Wall St. via Yahoo Finance· 25 minutes agoXeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and...
Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 3 hours agoHowever, keep in mind that even the best stocks will sometimes underperform the market over a twelve...
Jazz Jennings Is 'So Proud' of Recent Weight Loss, Talks Body Positivity at Any Size
ET Online via AOL· 1 hour agoJazz Jennings is celebrating body positivity. The 23-year-old reality star continues to open up...
MyHealthChecked Full Year 2023 Earnings: UK£0.003 loss per share (vs UK£0.029 profit in FY 2022)
Simply Wall St. via Yahoo Finance· 3 hours agoMyHealthChecked (LON:MHC) Full Year 2023 Results Key Financial Results Revenue: UK£11.0m (down 51%...
Investors in CareCloud (NASDAQ:CCLD) from three years ago are still down 63%, even after 12% gain...
Simply Wall St. via Yahoo Finance· 2 hours agoThe rise has some hopeful, but turnarounds are often precarious. On a more encouraging note the...
Clear Channel Outdoor Holdings (NYSE:CCO) investors are sitting on a loss of 73% if they invested...
Simply Wall St. via Yahoo Finance· 2 hours agoBecause Clear Channel Outdoor Holdings made a loss in the last twelve months, we think the market is...
It's Unlikely That The CEO Of Veracyte, Inc. (NASDAQ:VCYT) Will See A Huge Pay Rise This Year
Simply Wall St. via Yahoo Finance· 2 hours ago(NASDAQ:VCYT) has struggled to grow and now shareholders are sitting on a loss. What...
NIO Loss Widens on Lower EV Sales but Expects Stronger Second Quarter — Update
Morningstar· 1 hour agoThe Chinese EV maker on Thursday posted a net loss of 5.26 billion yuan ($725.7 million), compared with a CNY4.80 billion loss a year ...
Is Viking Therapeutics Stock a Buy on the Dip?
The Motley Fool via AOL· 2 hours agoViking Therapeutics (NASDAQ: VKTX) is an anomaly of sorts. Despite another underwhelming year for biotech stocks, the metabolic disease specialist has,...
Gazprom faces decade-long journey trying to recover lost revenues from Ukraine war after years of...
Fortune via Yahoo Finance· 3 hours agoGazprom slumped to its first loss in 20 years in 2023, hemorrhaging 629 billion roubles ($7.1...